Acadia Healthcare (ACHC) director Daniel Cancelmi files zero-share Form 3

Rhea-AI Filing Summary

Acadia Healthcare Company, Inc. director Daniel J. Cancelmi filed an initial ownership report on Form 3 for the company’s common stock. The filing shows a direct holding entry with total common shares beneficially owned following the reported date stated as 0.0000 shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Cancelmi Daniel J

Role Director

Type	Security	Shares	Price	Value
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 0 shares (Direct)

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

Accepted by SEC EDGAR 03/18/2026 - 06:15 PM Learn about SEC filing dates

FAQ

What does Daniel J. Cancelmi’s Form 3 for Acadia Healthcare (ACHC) show?

The Form 3 shows Daniel J. Cancelmi as a director of Acadia Healthcare Company, Inc. with a holding entry in common stock and total shares beneficially owned following the reported date stated as 0.0000 shares held directly.

Is there any buy or sell transaction reported in this Acadia Healthcare (ACHC) Form 3?

No buy or sell transactions are reported. The Form 3 reflects an initial ownership statement with a holding entry only, and the total common shares beneficially owned following the reported date are listed as 0.0000 shares held directly.

What security is covered in Daniel J. Cancelmi’s Acadia Healthcare (ACHC) Form 3?

The filing covers Common Stock of Acadia Healthcare Company, Inc. It records an initial ownership position for the director and shows total common shares beneficially owned following the reported date as 0.0000 shares held directly.

Does the Acadia Healthcare (ACHC) Form 3 indicate any derivative securities for Daniel J. Cancelmi?

The Form 3 derivative section is empty, indicating no derivative securities, such as options or warrants, are reported for Daniel J. Cancelmi in this filing. Only a holding entry for common stock with 0.0000 shares owned following the date appears.

What ownership type is indicated for Daniel J. Cancelmi in the Acadia Healthcare (ACHC) Form 3?

The filing classifies his ownership as direct. The common stock entry shows total shares beneficially owned following the reported date as 0.0000 shares, with the ownership code marked as direct rather than indirect through another entity.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Cancelmi Daniel J

(Last) (First) (Middle)

ACADIA HEALTHCARE COMPANY, INC.

4020 ASPEN GROVE DRIVE, SUITE 900

(Street)

FRANKLIN TENNESSEE 37067

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/12/2026

3. Issuer Name and Ticker or Trading Symbol
Acadia Healthcare Company, Inc. [ ACHC ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	0	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Brian Farley as Attorney in Fact for Daniel J. Cancelmi	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)